Diagnostics (Nov 2021)

Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases

  • Manabu Natsumeda,
  • Hironaka Igarashi,
  • Ramil Gabdulkhaev,
  • Haruhiko Takahashi,
  • Kunio Motohashi,
  • Ryosuke Ogura,
  • Jun Watanabe,
  • Yoshihiro Tsukamoto,
  • Kouichirou Okamoto,
  • Akiyoshi Kakita,
  • Tsutomu Nakada,
  • Yukihiko Fujii

DOI
https://doi.org/10.3390/diagnostics11112129
Journal volume & issue
Vol. 11, no. 11
p. 2129

Abstract

Read online

We have previously published a study on the reliable detection of 2-hydroxyglutarate (2HG) in lower-grade gliomas by magnetic resonance spectroscopy (MRS). In this short article, we re-evaluated five glioma cases originally assessed as isocitrate dehydrogenase (IDH) wildtype, which showed a high accumulation of 2HG, and were thought to be false-positives. A new primer was used for the detection of IDH2 mutation by Sanger sequencing. Adequate tissue for DNA analysis was available in 4 out of 5 cases. We found rare IDH2 mutations in two cases, with IDH2 R172W mutation in one case and IDH2 R172K mutation in another case. Both cases had very small mutant peaks, suggesting that the tumor volume was low in the tumor samples. Thus, the specificity of MRS for detecting IDH1/2 mutations was higher (81.3%) than that originally reported (72.2%). The detection of 2HG by MRS can aid in the diagnosis of rare, non-IDH1-R132H IDH1 and IDH2 mutations in gliomas.

Keywords